Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 8, 2007, Pages 1355-1361

  Rollin, Guilherme ^a,b,d   Ferreira, Nelson Pires ^c   Czepielewski, Mauro A ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL SÃO JOSÉ   (Brazil)

^d NONE   (Brazil)

Author keywords

Cushing's disease; Remission rates; Transsphenoidal pituitary surgery

Indexed keywords

EID: 38649136956     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000800022     Document Type: Article

References (57)

1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab 2003;88: 5593-602.
2. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol 2004;61:768-77.
3. Findling JW, Raff H. Clinical review: Cushing's syndrome: Important issues in diagnosis and management. J Clin Endocrinol Metab 2006;91:3746-53.
4. Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, et al. Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 2006;91:7-13.
5. Laws ER, Reitmeyer M, Thapar K, Vance ML. Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery. Neurochirurgie 2002;48:294-9.
6. Semple PL, Vance ML, Findling JW, Laws ER. Transsphenoidal surgery for Cushing's disease: outcome in patients with a normal magnetic resonance imaging scan. Neurosurgery 2000;46:553-9.
7. Oldfeld EH. Cushing disease. J Neurosurg 2003;98:948-51.
8. Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 2003;98:967-73.
9. Reitmeyer M, Vance ML, Laws Jr ER. The neurosurgical management of Cushing's disease. Mol Cell Endocrinol 2002;197:73-9.
10. Salassa RM, Laws ER, Carpenter PC, Northcutt RC. Cushing's disease - 50 years later. Trans Am Clin Climatol Assoc 1982;94:122-9.
11. Semple CG, Thomson JA, Teasdale GM. Transsphenoidal microsurgery for Cushing's disease. Clin Endocrinol (Oxf) 1984;21:621-9.
12. Shimon I, Ram Z, Cohen ZR, Hadani M. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 2002;51:57-62.
13. Zada G, Kelly DF, Cohan P, Wang C, Swerdloff R. Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions. J Neurosurg 2003;98:350-8.
14. Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 1995;80:3114-20.
15. Chee GH, Mathias DB, James RA, Kendall-Taylor P. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin Endocrinol (Oxf) 2001;54:617-26.
16. Dickerman RD, Oldfield EH. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 2002;97:1343-9.
17. Lamberts SW, van der Lely AJ, de Herder WW. Transsphenoidal selective adenomectomy is the treatment of choice in patients with Cushing's disease. Considerations concerning preoperative medical treatment and the long-term follow-up. J Clin Endocrinol Metab 1995;80:3111-3.
18. Mampalam TJ, Tyrrell JB, Wilson CB. Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med 1988;109:487-93.
19. Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab 2003;88:5858-64.
20. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 2002;56:541-51.
21. Sheehan JM, Lopes MB, Sheehan JP, Ellegala D, Webb KM, Laws Jr ER. Results of transsphenoidal surgery for Cushing's disease in patients with no histologically confirmed tumor. Neurosurgery 2000;47:33-9.
22. Simmons NE, Alden TD, Thorner MO, Laws Jr ER. Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg 2001;95:1-8.
23. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, et al. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxford) 1993;38:73-8.
24. Estrada J, Garcia-Uria J, Lamas C, Alfaro J, Lucas T, Diez S, et al. The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 2001;86:5695-9.
25. Flitsch J, Knappe UJ, Ludecke DK. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease. Zentralbl Neurochir 2003;64:6-11.
26. Yap LB, Turner HE, Adams CB, Wass JA. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clin Endocrinol (Oxford) 2002;56:25-31.
27. Ram Z, Nieman LK, Cutler Jr GB, Chrousos GP, Doppman JL, Oldfield EH. Early repeat surgery for persistent Cushing's disease. J Neurosurg 1994;80:37-45.
28. Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, et al. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. J Clin Endocrinol Metab 2004;89:6348-57.
29. Swearingen B, Biller BM, Barker 2nd FG, Katznelson L, Grinspoon S, Klibanski A, et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 1999;130:821-4.
30. Blevins Jr LS, Christy JH, Khajavi M, Tindall GT. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 1998;83:63-7.
31. Cannavo S, Almoto B, Dall'Asta C, Corsello S, Lovicu RM, De Menis E, et al. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Eur J Endocrinol 2003;149:195-200.
32. Damiani D, Aguiar CH, Crivellaro CE, Galvão JA, Dichtchekenian V, Setian N. Pituitary macroadenoma and Cushing's disease in pediatric patients: patient report and review of the literature. J Pediatr Endocrinol Metab 1998;11:665-9.
33. Semple PL, Laws Jr ER. Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease. J Neurosurg 1999;91:175-9.
34. Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 1997;40:225-36; discussion 236-7.
35. Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Vila-Porcile E, Olivier L, et al. Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow up studies. J Clin Endocrinol Metab 1988;66:1056-64.
36. Lamberts SWJ, van der Lely AJ, de Herder WW. Transsphenoidal selective adenomectomy is the treatment of choice in patients with Cushing's disease. Considerations concerning preoperative medical treatment and the long follow up. J Clin Endocrinol Metab 1995;80:3111-3.
37. Massoud AF, Powell M, Williams RA, Hindmarsh PC, Brook CG. Transsphenoidal surgery for pituitary tumours. Arch Dis Child 1997;76:398-404.
38. Hoybye C, Grenback E, Thoren M, Hulting A, Lundblad L, Von Holst H, et al. Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases. J Neurosurg 2004;100:634-8.
39. Rollin GAFS, Ferreira NP, Junges M, Gross JL, Czepielewski MA. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease. J Clin Endocrinol Metab 2004;89:1131-9.
40. Hofmann BM, Fahlbusch R. Treatment of Cushing's disease: A retrospective clinical study of the latest 100 cases. In: Laws ER Jr, Sheehan JP (eds). Pituitary Surgery - A Modern Approach. vol 34. Basel: Karger, 2006. pp. 158-84.
41. Netea-Maier RT, van Lindert EJ, den Heijer M, van der Eerden A, Pieters GFFM, Sweep CGJ, et al. Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease. Eur J Endocrinol 2006;154:675-84.
42. Hardy J. Cushing's disease: 50 years later. Can J Neurol Sci 1982;4:375-80.
43. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 1996;81:2647-52.
44. Pieters GF, Hermus AR, Meijer E, Smals AG, Kloppenborg PW. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease. J Clin Endocrinol Metab 1989;69:1122-6.
45. Barbetta L, Dall'Asta C, Tomei G, Locatelli M, Giovanelli M, Ambrosi B. Assessment of cure and recurrence after pituitary surgery for Cushing's disease. Acta Neurochir (Wien) 2001;143:477-81; discussion 481-2.
46. Invitti C, Giraldi FP, de Martin M, Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 1999;84:440-8.
47. Utz AL, Swearingen B, Biller BM. Pituitary surgery and postoperative management in Cushing's disease. Endocrinol Metab Clin North Am 2005;34:459-78.
48. Acebes JJ, Martino J, Masuet C, Montanya E, Soler J. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease. Acta Neurochir (Wien) 2007;149:471-7.
49. Locatelli M, Vance ML, Laws ER. Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 2005;90:5478-2.
50. Melby JC. Therapy of Cushing's disease: a consensus for pituitary microsurgery. Ann Intern Med 1988;109:445-6.
51. Zervas NT. Reflections on the surgery of the pituitary. Clin Neurosurg 1980;27:124-32.
52. Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB, et al. Repeat transsphenoidal surgery for Cushing's disease. J Neurosurg 1989;71:520-7.
53. Benveniste RJ, King WA, Walsh J, Lee JS, Delman BN, Post KD. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg 2005;102:1004-12.
54. Pouratian N, Prevedello DM, Jagannathan J, Lopes MB, Lee Vance M, Laws Jr. ER. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery. J Clin Endocrinol Metab 2007;92:3383-8.
55. Rollin G, Czepielewski MA. Cushing's syndrome: Is it possible a standard and simple diagnostic approach? Arq Bras Endocrinol Metab 2003;47:368-80.
56. Bakiri F, Tatai S, Aouali R, Semrouni M, Derome P, Chitour F, et al. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up. J Endocrinol Invest 1996;19:572-8.
57. Comtois R, Beauregard H, Hardy J, Robert F, Somma M. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma. Clin Endocrinol (Oxford) 1993;38:601-7.